abstract |
The present invention includes a method of treating an interferon gamma (IFN-y) -mediated disease using an IFN-y inhibitor, for example, an anti-huIFN-y antibody, wherein the expression level of one or more biomarkers is IFN lt; RTI ID = 0.0 > and / or < / RTI > Further, a therapeutic method using a specific pharmacological effect amount of the anti-huIFN-y antibody is anticipated. |